Home Cart 0 Sign in  
X

[ CAS No. 108381-23-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 108381-23-3
Chemical Structure| 108381-23-3
Chemical Structure| 108381-23-3
Structure of 108381-23-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 108381-23-3 ]

Related Doc. of [ 108381-23-3 ]

Alternatived Products of [ 108381-23-3 ]

Product Details of [ 108381-23-3 ]

CAS No. :108381-23-3 MDL No. :MFCD22572316
Formula : C9H11ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :QWWCHVHQVYFMJU-UHFFFAOYSA-N
M.W : 214.65 Pubchem ID :59868739
Synonyms :

Calculated chemistry of [ 108381-23-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.44
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 53.06
TPSA : 52.08 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.06 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.61
Log Po/w (XLOGP3) : 2.18
Log Po/w (WLOGP) : 1.92
Log Po/w (MLOGP) : 1.1
Log Po/w (SILICOS-IT) : 2.62
Consensus Log Po/w : 2.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.66
Solubility : 0.466 mg/ml ; 0.00217 mol/l
Class : Soluble
Log S (Ali) : -2.91
Solubility : 0.266 mg/ml ; 0.00124 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.53
Solubility : 0.0632 mg/ml ; 0.000294 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.04

Safety of [ 108381-23-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 108381-23-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 108381-23-3 ]
  • Downstream synthetic route of [ 108381-23-3 ]

[ 108381-23-3 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 168130-75-4 ]
  • [ 108381-23-3 ]
YieldReaction ConditionsOperation in experiment
60.9% at 80℃; for 2 h; Inert atmosphere To a solution of POCl3(10.42 mL 122 mmol) and DIEA (33 mL 189 mmol) stirred under N2at 20 was added ethyl 4 6-dimethyl-2-oxo-1 2-dihydropyrimidine-5-carboxylate (2.4 g 12.23 mmol) slowly. The reaction mixture was stirred at 80 for 2 hr. Then the solution was concentrated and distributed between EA and saturated NaHCO3solution. The combined organic extract was washed with brine dried over Na2SO4 filtered and concentrated. The residue was purified by silica column chromatography (PE/EA 101) . All fractions found to contain product by TLC (PE/EA 101 Rf 0.7) were combined and concentrated to yield yellow oil of ethyl 2-chloro-4 6-dimethylpyrimidine-5-carboxylate (1.6 g 7.45 mmol 60.9yield) 1HNMR(400 MHz CDCl3) δ4.43 (q J 6.8 Hz 2H) 2.54 (s 6H) 1.40 (t J 7.1 Hz 3H) ES-LCMS m/z 215.1 (M+H) .
30% at 105℃; for 3 h; 3.
Synthesis of ethyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate
Into a 100-mL round-bottom flask, was placed a solution of ethyl 4,6-dimethyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (300 mg, 1.53 mmol, 1.00 equiv) in phosphoroyl trichloride (10 mL), N,N-Diethylaniline (0.1 mL, 0.10 equiv).
The resulting solution was stirred for 3 hours at 105° C. in an oil bath.
The reaction was then quenched by the addition of water.
The resulting solution was extracted with ethyl acetate and the organic layers combined and concentrated under vacuum.
This resulted in 100 mg (30percent) of ethyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate as a yellow solid. m/z: 214.85[MH+], tR=0.842 min (1.90 minute run).
Reference: [1] Patent: WO2016/37578, 2016, A1, . Location in patent: Page/Page column 213; 214
[2] Patent: US2018/99940, 2018, A1, . Location in patent: Paragraph 0563
[3] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 82 - 97
[4] European Journal of Medicinal Chemistry, 2015, vol. 100, # 1, p. 1 - 9
[5] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 266 - 273
  • 2
  • [ 168130-75-4 ]
  • [ 108381-23-3 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With N-benzyl-N,N,N-triethylammonium chloride; <i>N</i>,<i>N</i>-dimethyl-aniline; trichlorophosphate In acetonitrile for 5 h; reflux
Stage #2: With sodium hydrogencarbonate In water; acetonitrile
Step 2.
Synthesis of ethyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate, 6b
Phosphorus oxychloride (2.8 ml, 30 mmol) was added to a mixture of 6a (1.47 g, 7.5 mmol), benzyltriethylammonium chloride (1.71 g, 7.5 mmol) and N,N-dimethylaniline (1.82 g, 15 mmol) in acetonitrile (30 ml).
The mixture was reflux for 5 hours.
The mixture was poured into ice water and neutralized with NaHCO3.
The solution was extracted with ethyl acetate.
The organic layer washed with brine, dried over MgSO4, concentrated and chromatographed to obtain 6b, (1.02 g, 4.75 mmol, 63percent).
39% at 110℃; for 2 h; To a solution of POCI3 (106ml) and DIEA (65ml) was added 4,6-dimethyl-2-hydroxy-pyrimi- dine-5-carboxylic acid ethyl ester (21.9mg, 111.6mmol). The mixture was heated to 110°C for 2h. Excess POCI3 and DIEA were removed by evaporation under reduced pressure. The residue was dissolved in EtOAc (1.21) and treated with decolorizing carbon. After filtration, the solution was washed with IN NaOH, water and brine. The organic layer was dried over Na2S04. filtered and concentrated. The crude residue was purified by flash chromatography with a 0-30percent EtOAc in hexane gradient to afford the desired product (9.33g, 39percent yield).
39% at 110℃; for 2 h; Preparation of 2-Chloro-4,6-dimethyl-pyrimidine-5-carboxylic acid ethyl ester
To a solution of POCl3 (106 ml) and DIEA (65 ml) was added 4,6-dimethyl-2-hydroxy-pyrimidine-5-carboxylic acid ethyl ester (21.9 mg, 111.6 mmol).
The mixture was heated to 110° C. for 2 h.
Excess POCl3 and DIEA were removed by evaporation under reduced pressure.
The residue was dissolved in EtOAc (1.21) and treated with decolorizing carbon.
After filtration, the solution was washed with 1N NaOH, water and brine.
The organic layer was dried over Na2SO4. filtered and concentrated.
The crude residue was purified by flash chromatography with a 0-30percent EtOAc in hexane gradient to afford the desired product (9.33 g, 39percent yield).
Reference: [1] Patent: US2008/318979, 2008, A1, . Location in patent: Page/Page column 23
[2] Patent: WO2012/123467, 2012, A1, . Location in patent: Page/Page column 28
[3] Patent: US2013/197059, 2013, A1, . Location in patent: Paragraph 0125; 0126
  • 3
  • [ 141-97-9 ]
  • [ 108381-23-3 ]
Reference: [1] Patent: WO2012/123467, 2012, A1,
[2] Patent: US2013/197059, 2013, A1,
[3] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 266 - 273
[4] Patent: WO2016/37578, 2016, A1,
[5] Patent: US2018/99940, 2018, A1,
  • 4
  • [ 17994-56-8 ]
  • [ 108381-23-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 82 - 97
[2] Patent: US2013/197059, 2013, A1,
[3] European Journal of Medicinal Chemistry, 2015, vol. 100, # 1, p. 1 - 9
[4] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 266 - 273
[5] Patent: US2018/99940, 2018, A1,
  • 5
  • [ 17994-56-8 ]
  • [ 108381-23-3 ]
Reference: [1] Patent: WO2012/123467, 2012, A1,
Recommend Products
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 108381-23-3 ]

Chlorides

Chemical Structure| 188781-08-0

[ 188781-08-0 ]

Ethyl 2-chloro-4-methylpyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 499195-60-7

[ 499195-60-7 ]

Ethyl 4-(2-chloropyrimidin-4-yl)benzoate

Similarity: 0.80

Chemical Structure| 188781-10-4

[ 188781-10-4 ]

2-Chloro-4-methylpyrimidine-5-carboxylic acid

Similarity: 0.79

Chemical Structure| 187035-79-6

[ 187035-79-6 ]

Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate

Similarity: 0.78

Chemical Structure| 89793-12-4

[ 89793-12-4 ]

Ethyl 2-chloropyrimidine-5-carboxylate

Similarity: 0.78

Esters

Chemical Structure| 188781-08-0

[ 188781-08-0 ]

Ethyl 2-chloro-4-methylpyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 499195-60-7

[ 499195-60-7 ]

Ethyl 4-(2-chloropyrimidin-4-yl)benzoate

Similarity: 0.80

Chemical Structure| 187035-79-6

[ 187035-79-6 ]

Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate

Similarity: 0.78

Chemical Structure| 89793-12-4

[ 89793-12-4 ]

Ethyl 2-chloropyrimidine-5-carboxylate

Similarity: 0.78

Chemical Structure| 110960-73-1

[ 110960-73-1 ]

Ethyl 4-methylpyrimidine-5-carboxylate

Similarity: 0.78

Related Parent Nucleus of
[ 108381-23-3 ]

Pyrimidines

Chemical Structure| 188781-08-0

[ 188781-08-0 ]

Ethyl 2-chloro-4-methylpyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 499195-60-7

[ 499195-60-7 ]

Ethyl 4-(2-chloropyrimidin-4-yl)benzoate

Similarity: 0.80

Chemical Structure| 188781-10-4

[ 188781-10-4 ]

2-Chloro-4-methylpyrimidine-5-carboxylic acid

Similarity: 0.79

Chemical Structure| 187035-79-6

[ 187035-79-6 ]

Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate

Similarity: 0.78

Chemical Structure| 110960-73-1

[ 110960-73-1 ]

Ethyl 4-methylpyrimidine-5-carboxylate

Similarity: 0.78